Postdoctoral Fellow at the VU LSC EMBL Partnership Institute for Gene Editing Technologies (application deadline 2024-12-30, or until right candidate is appointed)
The Arias Laboratory is recruiting postdoctoral fellows interested in stem cells and immunology. We are seeking applicants who wish to pursue research in any of the following areas: (1) human induced pluripotent stem cell biology. (2) Gene editing. (3) Immunology and their thematic interactions. (4) Oncology and tumor biology.
Research focus: Our lab investigates the gene editing mechanisms on human iPSCs and immune effector derivatives. We study how to implement and improve gene editing technologies on human systems. We use human iPSCs and combine molecular, cellular, developmental and bioinformatics approaches to establish disease modelling and therapeutic prototyping approaches. We also seek to understand how gene editing affect the genome.
Collaborations: This project benefits from local and international RnD collaborations.
Lab expertise: The lab specializes in genome engineering methodologies in human iPSCs to implement developmental biology principles for disease modelling and therapeutic prototyping.
Application Requirements:
Ph.D. degree in life sciences, biochemistry, cell biology, developmental biology or other related biotechnology fields,
Publications from prior training. Ideally >=1 first or co-first author publication, ideally in a Q1 journal.
Prior experience in any of the following relevant areas is highly desired: Developmental Biology, genetics, gene editing, stem cell biology, cancer biology, cell biology and bioinformatics.
Candidates from Taiwan are encouraged to apply.
To apply: Please email your CV (pdf) and a short cover letter summarizing your experience (pdf), ORCID number (e-mail text), along with the contact information of two references (e-mail text) to the group leader (). Observe that only applications directed through this channel will be considered.
Why join us
The Vilnius University Life Sciences Center and European Molecular Biology Laboratory (LSC-EMBL) partnership institute is a highly collaborative center to advance genome editing technologies. Our mission is to develop next generation editing tools. The LSC and EMBL are institutions of world-class research, very collegial working environments and excellent up-to-date infrastructures. The Life Sciences Center (VU LSC) in itself is a faculty level operational unit of Vilnius University (VU, which is a major public research and higher education institution in Lithuania). VU LSC conducts scientific research, studies and technological development in disciplines including biochemistry, molecular biology, genetics, neurobiology, molecular medicine, biotechnology, cell and structural biology and other related sciences. The Center is home to 250 PhD degree researchers and around 1,000 undergraduate and postgraduate students. Integration of studies and research provides an incoming stream of young talents.
Responsibilities
Conduct research on gene editing of human iPS cells, immune effector cells.
Understand technological trends and integrate emerging technologies to own projects.
Oversight and mentor the RnD activates of junior associates.
Analyze datasets and draft research articles.
Qualifications
You currently hold a PhD degree or are scheduled to obtain one soon.
Fluent communication in oral and written English. Degree obtained in EN and, TOEFL or other language certifications.
Have published at least one scientific research article as first author.
Experience in cell biology, cancer, metabolism or compatible RnD areas.
Experience in molecular biology or compatible RnD areas.
Experience in programming in python, octave, R and or bash is desirable.
Experience in gene editing is desirable.
Application deadline: December 30th, 2024 or untill the ideal candidate identified.
Prospective employment starting day: Mutually agreed with ideal candidate
If you are interested in job opportunities at the Life Sciences Center, send your CV and cover letter by e-mail to .
Confidentiality is guaranteed.